Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VADT
NCT00032487Phase 3Completed
- Sponsor
- VA Office of Research & Development
- Start
- Dec 2000
- Primary completion
- May 2008
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of human insulin, glimepiride, rosiglitazone, metformin in type 2 diabetes mellitus (T2DM), sponsored by VA Office of Research & Development. Started Dec 2000; status: completed.
02
Drugs
human insulinglimepiriderosiglitazonemetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00032487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00032487.